DASCA – The Designer Anabolic Steroid Control Act of 2014

The Designer Steroid Control Act of 2014 (H.R. 4771), the latest in a long line of legislative actions intended to bring an end to the sale of anabolic steroids, was passed by a voice vote in the House of Representatives recently. The bill still needs to pass the Senate before being signed into law by the President, but the writing’s very much on the wall for the designer steroid market.
There’s a lot of misunderstanding and misinformation surrounding DASCA, with some people claiming that it would outlaw anything that builds muscle, including things like protein and creatine, and others suggesting it just adds 25 new compounds to the Controlled Substances Act, and yet others claiming that prohormones would be fine if sold as “research chemicals”, so lets take a look at the bill in a little more detail.
Continue reading

Superdrol and Prostanozol: Schedule III Drugs

The DEA recently published a final ruling on the classification of the steroids methasterone and prostanozol as anabolic steroids under Schedule III of the Controlled Substances Act. This was proposed in November of last year and has now been signed into action, coming into effect on the 29th August 2012.

The two steroids have been determined to be chemically and pharmacologically related to testosterone and are not estrogens, progestins, corticosteroids, or dehydroepiandrosterone according to the criteria that classifies anabolic steroids in the Controlled Substances Act.
Continue reading